Exchange: NASDAQ·Updated 07:30 PM EDT

LKFT Lakefront Biotherapeutics NV - ADR

$29.37
$0.51
(1.77%)
Today
Closed $29.37
$0.00
(0.00%)
After Hours
EarningsNov 11
Mkt Cap$1.93B
Vol270,234.00

About LKFT

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
55

Bullish Sentiment

How do you feel about LKFT?

Advertisement|Remove ads.